BOQI International Medical Inc. Announces Its Hospital to Be Put Into Use As Official COVID-19 Vaccination Site in China
May 05 2021 - 8:00AM
BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the
“Company”), a leading healthcare products and services provider in
China, today announced that Chaohu Zhongshan Minimally Invasive
Hospital (“Zhongshan Hospital”), one of the hospitals under the
umbrella of the Company’s gynecology-focused hospital chain in
China, was informed by China Anhui Province Chaohu City’s Center
for Disease Control and Prevention that it will soon be used as an
official COVID-19 vaccination site in China.
Zhongshan Hospital had established a leaders’ working group that
held multiple symposiums to prepare Zhongshan Hospital to meet the
safety standards required for onsite vaccination in China. The
vaccination site has been divided into six zones that include
waiting area, health consultation area, registration area,
vaccination space, observation room and an emergency room to
prevent potential cross-infection.
China Anhui Province recently launched an action plan that aims
to speed up vaccinations against COVID-19 for target population
groups. It is estimated that more than 40 percent of the over 60
million permanent resident population in Anhui Province will be
vaccinated by June 30, 2021.
Mr Tiewei Song, Chief Executive Officer and President of the
Company, commented: “We are delighted that Zhongshan Hospital is
able to join forces with peer hospitals and institutions to help
facilitate universal vaccination against COVID-19 in China. Since
BIMI completed its acquisition of Zhongshan Hospital in February,
Zhongshan Hospital has been working closely with the support from
Chaohu City’s Health Commission and Center for Disease Control and
Prevention to implement preparations for the hospital to meet the
standards for a COVID-19 vaccination site.”
About BOQI International Medical Inc.
BOQI International Medical Inc. was founded in 2006. In February
2019, the Board of Directors of the Company determined to focus on
the healthcare industry. The Company is now exclusively a
healthcare products and provider, offering a broad range of
healthcare products and related services and operates two private
hospitals. For more information, please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are
forward-looking statements that involve a number of risks and
uncertainties including, but not limited to, the Company’s ability
to achieve profitable operations, its ability to continue to
operate as a going concern, its ability to continue to meet NASDAQ
continued listing requirements, the effects of the spread of the
Coronavirus (COVID-19), the demand for the Company’s products and
services in the People’s Republic of China, general economic
conditions and other risk factors detailed in the Company’s annual
report and other filings with the United States Securities and
Exchange Commission.
Investor Relations Contact:
Janice Wang
EverGreen Consulting Inc.
Email: IR@changqingconsulting.com
Phone: +1 571-464-9470 (from
U.S.)
+86 13811768559 (from China)
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Apr 2023 to Apr 2024